Spark Biomedical, a commercial-stage bioelectronic medicine company pioneering non-invasive multi-path neurostimulation devices, announced ...

Collagen is the most abundant protein in the human body, making up about 30% of total protein and providing structure, ...

MintNeuro, a semiconductor company building specialised chips for neural devices from implants to wearables, today announces a $5 ...

Crystal structures of an engineered hyperthermophilic sugar dehydrogenase reveal how two mutations relieve a steric barrier ...

A soft bioelectronic system with a thermally responsive hydrogel interface gives neurosurgeons real-time, quantitative ...

Over the last century, pharmacology has revolutionized the practice of medicine. Our next revolution in medicine may come with bioelectronic treatments that reduce inflammation.

Our team is focused on developing a new class of bioelectronic macrodevices that can maintain the viability of therapeutic cells in hostile transplant sites without the need for immune suppression.

Disclaimer: Generative AI was used in the creation of this article. While the content has been organized after researching ...

The collaboration pairs Firefly's AI-powered brain-assessment platform with NeuroSigma's FDA-cleared, non-medication device ...

Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that it has received ...

Cala®, the bioelectronic medicine leader, today announced nationwide availability of the Cala kIQ® Plus System, the latest ...

A University of Maryland-led project received a $17.3 million National Science Foundation award to create an AI-powered and ...